Semaglutide Gets FDA Greenlight for MASH

By News Health
2 months Ago

(MedPage Today) — The FDA expanded the indication for semaglutide (Wegovy) to treating adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), the agency announced.
The glucagon-like peptide-1 (GLP-1) receptor agonist…

Source link : https://www.medpagetoday.com/gastroenterology/generalhepatology/117043

Author :

Publish date : 2025-08-18 18:20:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Head-to-Head Trial Supports New Treatment for Kids With MS

NHS boss Sir Jim Mackey backed heart surgeon whose failures contributed to deaths

Expert advice and how to avoid the worst

Early At-Home Abortion: As Safe As in the Hospital?

UV Air Purification May Aid Endoscopy Room Decontamination

Parkinson's Risk Rises With Outdoor Air Chemical Exposure